Excessive Daytime Sleepiness Market Insights and Treatment Market by DelveInsight

Excessive Daytime Sleepiness Market Insights and Treatment Market by DelveInsight

Excessive Daytime Sleepiness Market” report has been added to DelveInsight


Excessive Daytime Sleepiness disease Overview

Excessive daytime sleepiness (EDS) as a serious symptom that can have many different causes; however, it is not a disorder in itself. It frequently occurs in the general population and is a common feature of many other psychiatric conditions particularly affective disorders (e.g., depression, atypical depression, seasonal affective disorder) and psychosis (e.g., schizophrenia), and in patients taking certain psychiatric medications (e.g., benzodiazepines, tricyclic antidepressants).


Get a free sample copy now- https://www.delveinsight.com/sample-request/excessive-daytime-sleepiness-eds-market


Excessive Daytime Sleepiness Market: Regions Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Excessive Daytime Sleepiness Market Company

  • Jazz Pharmaceuticals


Excessive Daytime Sleepiness Drugs

  • Sunosi
  • JZP-258


Excessive Daytime Sleepiness Symptoms

Excessive sleepiness is a common symptom that may be related to sleep deprivation or other sleep disorders, such as narcolepsy, Obstructive Sleep Apnea (OSA), and SWSD (Shift Work Sleep Disorder). It is estimated that 20% of the population can be classified as having Excessive Sleepiness (sometimes referred to as Excessive Daytime Sleepiness).


Excessive Daytime Sleepiness Causes

The common causes of EDS are poor sleep habits, such as a reduced opportunity for sleep or irregular sleep schedule, a sleep disorder like Obstructive Sleep Apnea, side effects from certain medications, and other underlying medical conditions.


Excessive Daytime Sleepiness Market Insights

Excessive daytime sleepiness (EDS) is a highly prevalent complaint associated with significant adverse effects on health, workplace and academic performance, absenteeism, and overall health and safety. The treatment of EDS is based on the underlying cause of the condition. Traditionally, amphetamine-like stimulants (i.e., dopaminergic release enhancers) have been used for clinical management to improve EDS, along with tricyclic antidepressants, which have been used as anticataplectics.


Excessive Daytime Sleepiness Market Report

The underlying cause of the EDS determines the type of treatment given to the patients. These include non-pharmacologic approaches; pharmacologic treatments (sympathomimetic agents; caffeine, etc.); Central Nervous Stimulants [Methylphenidate (Ritalin, Ritalin SR, Methylin, Methylin ER), Mixed Amphetamine Salts (Adderall IR, Adderall XR), Dextroamphetamine (Dexedrine, Dexedrine SR), Lisdexamfetamine (Vyvanse)] and other rapid eye movement (REM) sleep medications.


Excessive Daytime Sleepiness Market Research Report

In the case of sleep apnea, a continuous positive airway pressure (CPAP) machine can be used. Medication can also be prescribed for patients with narcolepsy to help them remain awake and productive during the day. Shift workers who persistently feel sleepy during work hours may also benefit from medication if adjusting sleep habits does not help, or if rotating schedules make it challenging to sleep sufficiently. In case of failure behavioral changes to improve sleep, medication may be an option.


Excessive Daytime Sleepiness Market Research

Previously approved therapeutics includes Modafinil (Provigil) and armodafinil (Nuvigil), which are the possible medications to treat excessive sleepiness. These medications work by changing the action of certain chemicals in the brain and have “monoaminergic” effects (altering neurotransmitters like dopamine and serotonin). Other possible medications are stimulants, such as methylphenidate (Ritalin).


Excessive Daytime Sleepiness Market Report Highlights

  • The increasing prevalence of the disease along with promising emerging pipeline therapies will positively drive the EDS market.
  • The companies and academics are working to assess challenges and seek opportunities that could influence EDS R&D.
  • Major players are involved in developing therapies for EDS. The launch of emerging therapies will significantly impact the EDS market.
  • Our in-depth analysis of the pipeline assets across different stages of development (phase III and phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.


Get a free sample copy now- https://www.delveinsight.com/sample-request/excessive-daytime-sleepiness-eds-market


Table of content

1. Key Insights

2. Executive Summary of Excessive Daytime Sleepiness (EDS)

3. Competitive Intelligence Analysis for Excessive Daytime Sleepiness (EDS)

4. Excessive Daytime Sleepiness (EDS) : Market Overview at a Glance

5. Excessive Daytime Sleepiness (EDS) : Disease Background and Overview

6. Patient Journey

7. Excessive Daytime Sleepiness (EDS) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Excessive Daytime Sleepiness (EDS) Treatment

11. Marketed Products

12. Emerging Therapies

13. Excessive Daytime Sleepiness (EDS) : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Excessive Daytime Sleepiness (EDS)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight


In conclusion, this report provides information such as causes, symptoms, treatment, and Market report, Market Research, Market Drivers, Market Barriers and SWOT Analysis are also incorporated in the report





Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/